Enterprise Dose Monitoring

2026-11-03

Request for Information ( RFI ) of Small Business capability for the Defense Health Agency ( DHA ) Enterprise Dose Monitoring System1 . 0 DISCLAIMER : This is NOT a Request for Proposal ( RFP ) nor a Request for Quotation ( RFQ ). It is strictly a Request for Information ( RFI ) to determine if Small Business is capable of meeting the Government ’ s requirement . Only Small Business responses will be considered . This RFI should not be construed as a formal solicitation nor an obligation on the part of the Government to acquire any products or services . Neither unsolicited proposals nor any other kinds of offers will be considered in response to this RFI , and no contract will be awarded pursuant to this announcement . The information requested by this RFI will be used within the DHA to facilitate decision making and will not be disclosed outside of the DHA . Any information provided to the Government is strictly voluntary and will be provided at no cost to the Government . 2 . 0 SUBJECT : The Medical Research and Development Contracting Division 2 , Defense Health Agency Contracting Activity ( DHACA ), is seeking information in the form of capabilities statements and availability . This RFI is for fact - finding and planning purposes only . The information will be used in conducting market research to identify qualified , experienced , and interested potentialSmall Businesssources in support of the Government ’ s requirements outlined in Attachment 1 , which are subject to change prior to a formal solicitation release . The Government reserves the right to decide whether a small business set - aside is appropriate based on responses to this notice . Contractors are encouraged to inform the Government of any barriers that would prohibit them from competing . Contact with Government personnel , other than those specified in the RFI , by potential offerors or their employees regarding this requirement is not permitted . 3 . 0 BACKGROUND : The DHA relies on timely , accurate , and compliant dose monitoring to support patient safety , clinical decision making , and mission readiness . Clinicians and medical physicists manage high volumes of dose data , often under critical conditions like emergency care , trauma , and diagnostic imaging . As the DHA moves toward standardization , the goal is to consolidate dose monitoring into a single enterprise system with real - time analytics , integrated data workflows , and robust security to drive efficiency and compliance : Highly accurate , specialty - tuned dose monitoring calibrated for specialized imaging modalities . Rapid , uninterrupted data capture workflows that drive productivity and reduce report turnaround times . Secure handling of dose data containing Protected Health Information ( PHI ), ensuring compliance with the Health Insurance Portability and Accountability Act ( HIPAA ) and other regulatory requirements . Reliable operation in bandwidth - constrained environments , including Outside the Continental United States ( OCONUS ) Military Treatment Facilities ( MTFs ) and remote telemedicine missions . Seamless integration with existing Picture Archiving and Communication Systems ( PACS ), Radiology Information System ( RIS ), and Electronic Health Record ( EHR ) systems for unified dose tracking and reporting . An enterprise dose monitoring system must provide consistent data formatting , customizable templates , macro support , and the ability to capture specialized metrics across imaging modalities such as neuroradiology , Musculoskeletal ( MSK ), and Nuclear Medicine . The DHA seeks commercial solutions that can scale these capabilities while meeting cybersecurity , interoperability , and operational requirements in the Department of War ( DoW ) environment . 4 . 0 SCOPE : The Medical Research and Development Contracting Division 2 , DHACA , is issuing an RFI to identifySmall Businessescapable of meeting the Government ’ s requirement . The Government requests a Capability Statement outlining a proposed solution that includes the following : Enterprise dose monitoring solution that meets the DHA requirements for real - time dose tracking , clinical decision support , and regulatory compliance . Integrate with PACS , Military Health System ( MHS ) GENESIS / Cerner , and other DHA clinical systems . Comply with DoW cybersecurity , identity , and Zero - Trust policies . Support all Radiologists across CONUS and OCONUS sites . Operate effectively in variable network conditions . Provide a central system that has central administration , reporting , and access governance . A draft implementation plan outlining the potential solution to the Government ’ s requirement . The plan should highlight the key deliverables , timelines , and expectations of each party responsible for delivery , configuration , and final acceptance of the systems , and include the total number of project managers and implementation team ( s ) involved . Detailed steps and task owners for implementation as well as expected completion time for each task are requested . Please also provide timelines for production and implementation . Implementation is defined utilizing a “ Go - live ” date accomplished by full clinical usage of the system with fulfillment of migration requirements with no reliance on the legacy system . In addition , the Government requests feedback regarding potential risks and mitigation strategies . Vendors may also propose alternative or innovative approaches . In your capability statement , address how you would deliver / implement the specific tasks outlined in Attachment 1 . Task Areas : 1 . 0 System Architecture & Availability2 . 0 Workstation , PACS , and Operating System ( OS ) Integration3 . 0 Enterprise Workload , Templates , & Reporting4 . 0 Hardware & Peripheral Requirements5 . 0 Clinical Workflow & Critical Results6 . 0 DoW System Integration7 . 0 DoW Cybersecurity & Risk Management Framework ( RMF ) Requirements5 . 0 SMALL BUSINESS SET ASIDE : The Government has not determined the set - aside capability at this time . The Government will use the RFI results in analyzing small businesses ’ capacity to perform this requirement and make its decision . 6 . 0 RESPONSE INSTRUCTIONS : If your firm can provide the requirements described in Attachment 1 , please provide a Capability Statement to the Medical Research and Development Contracting Division 2 , DHACA , Ms . Jennifer Sikes , jennifer . m . sikes2 . civ @ health . mil . A vendor responding to this RFI with generic material only , such as brochures , advertisements , or other generic material , ishighly discouraged . The following information is requested :( a ) Capability Statement ( b ) company Cage Code , Unique Entity Identifier ( UEI ), company name , address , point of contact and their telephone number , email address and company structure ( Corporation , LLC , partnership , joint venture , etc .). Companies must be registered in the System for Award Management ( SAM , at www . sam . gov ) to be considered as potential sources .( c ) Small Business Designation status such as ( 8 ( a ), HUBZone , Service - Disabled Veteran Owned Small Business ( SDVOSB ), women - owned , etc .). Maximum participation by small business , veteran - owned small business , service - disabled veteran - owned small business , HUBZone small business , small - disadvantaged business , and women - owned small business concerns is encouraged .( d ) indicate which North American Industry Classification System ( NAICS ) code ( s ) your company usually performs under for Government contracts .( e ) Information pertaining to the following : Does your company participate in any contracting vehicles such as Government - wide Acquisition Contracts ( GWACS ), Multiple - Award Contracts ( MAC ) or Indefinite Delivery , Indefinite Quantity contracts ( IDIQ )? If so , please provide detailed information regarding which , contract numbers and relevant categories . Does your company have a Federal Supply Schedule ( FSS )? If so , please provide detailed information regarding which , schedule numbers and relevant categories . Submission : Please submit an electronic copy of the capabilities statement in a “. pdf ” file type and via email to the Medical Research and Development Contracting Division 2 , DHACA , Ms . Jennifer Sikes at jennifer . m . sikes2 . civ @ health . mil . The subject line of the email should be : “ Enterprise Dose Monitoring – RFI Response .” Due date : RFI response submission are due no later than . Page Limit : RFI responses shall be limited to 20 pages , not including cover and administrative pages , and written using a 12 - point font size . Beyond the 20 - page limit , the Government may only review examples of media and graphic design . Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract . Parties may begin submitting responses to this RFI immediately . If the information provided contains propriety information , such information must be clearly identified with appropriate disclaimers . THIS IS NOT A SOLICITATION ANNOUNCEMENT OR REQUEST FOR PROPOSALS , AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT .

Maryland

2026-05-02